📰 Eric Soyer News
Page 4 - Eric Soyer News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Eric Soyer. Real-time updates on events, politics, business and more.
February 15, 2023
Conference call and webcast in English on February 16, 2023 at 8:30am EST 02:30pm CET and in French on the same day at 12pm EST 6pm CET Strategic combination would build on complementary expertise
November 28, 2022
/PRNewswire/ -- The live musical stage production, "Picking the Stars" premiered in Xiamen, China, to a sold-out show and rave reviews. Based on the hit mobile...
October 13, 2022
ERYTECH Announces Receipt of Nasdaq Notice Cambridge, MA (U.S.) and Lyon (France), October 13, 2022 - ERYTECH Pharma (Nasdaq & Euronext: a clinical-stage biopharmaceutical company developing
September 12, 2022
ERYTECH Provides Business and Financial Update for the First Half of 2022 Conference call and webcast on Tuesday, September 13, 2022at 8:30am ET / 02:30pm CEST U.S. cell therapy
August 24, 2022
ERYTECH Provides Regulatory Update ERYTECH to stop further plans to pursue a BLA submission seeking an approval for Graspa in hypersensitive ALLEvaluation of strategic partnering options
June 24, 2022
REPORT - ERYTECH'S COMBINED SHAREHOLDERS' MEETING ON JUNE 24, 2022 Cambridge, MA (U.S.) and Lyon (France), June 24, 2022 - ERYTECH Pharma (Nasdaq & Euronext: ERYP), a clinical-stage
May 18, 2022
Press release content from Globe Newswire. The AP news staff was not involved in its creation.
May 13, 2022
ERYTECH Pharma S.A. (NASDAQ:NASDAQ:ERYP) Q1 2022 Earnings Conference Call May 13, 2022, 8:30 AM ET Company Participants Gil Beyen – Chief Executive Officer Eric Soyer – Chief Financial and...
May 12, 2022
ERYTECH Provides Business and Financial Update for the First Quarter of 2022 Conference call and webcast on Friday, May 13, 2022at 8:30am EDT / 02:30pm CEST U.S. cell therapy
May 12, 2022
12.05.2022 - ERYTECH Provides Business and Financial Update for the First Quarter of 2022 Conference call and webcast on Friday, May 13, 2022at 8:30am EDT / 02:30pm CEST U.S. cell therapy manufacturing facility sold to Catalent for a total ...